These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7446418

  • 1. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
    Leier CV, Desch CE, Magorien RD, Triffon DW, Unverferth DV, Boudoulas H, Lewis RP.
    Am J Cardiol; 1980 Dec 01; 46(6):1039-44. PubMed ID: 7446418
    [Abstract] [Full Text] [Related]

  • 2. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.
    Clin Pharmacol Ther; 1981 Jul 01; 30(1):23-30. PubMed ID: 7237894
    [Abstract] [Full Text] [Related]

  • 3. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Rouleau JL, Chatterjee K, Benge W, Parmley WW, Hiramatsu B.
    Circulation; 1982 Apr 01; 65(4):671-8. PubMed ID: 7037220
    [No Abstract] [Full Text] [Related]

  • 4. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH, Massie BM.
    Circulation; 1980 Jun 01; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract] [Full Text] [Related]

  • 5. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.
    Ann Intern Med; 1981 Jul 01; 95(1):5-13. PubMed ID: 7247126
    [Abstract] [Full Text] [Related]

  • 6. Clonidine in congestive heart failure: a vasodilator with negative inotropic effects.
    Hermiller JB, Magorien RD, Leithe ME, Unverferth DV, Leier CV.
    Am J Cardiol; 1983 Mar 01; 51(5):791-5. PubMed ID: 6829440
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
    Deglin SM, Jain AC, Harris WS.
    Cardiology; 1980 Mar 01; 66(4):193-8. PubMed ID: 7448835
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I, Tweddel AC, Bastian BC, Murray RG.
    Acta Med Scand Suppl; 1981 Mar 01; 652():163-8. PubMed ID: 6120615
    [No Abstract] [Full Text] [Related]

  • 9. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD.
    J Med Assoc Ga; 1980 Feb 01; 69(2):131-2. PubMed ID: 7373170
    [No Abstract] [Full Text] [Related]

  • 10. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS, Lurie M, Turbow M, Whittaker K, Van Camp S, Hughes D.
    Circulation; 1979 Feb 01; 59(2):344-50. PubMed ID: 365391
    [Abstract] [Full Text] [Related]

  • 11. New therapies in the management of congestive heart failure.
    Atkins FL.
    J Kans Med Soc; 1980 Feb 01; 81(2):83-5, 94. PubMed ID: 7351512
    [No Abstract] [Full Text] [Related]

  • 12. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov 01; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

  • 13. New approaches to managing congestive heart failure.
    Romankiewicz N.
    J Pract Nurs; 1983 Jan 01; 33(1):13-7. PubMed ID: 6338208
    [No Abstract] [Full Text] [Related]

  • 14. Chronic afterload reduction in the treatment of congestive heart failure.
    Feldman R.
    J Iowa Med Soc; 1983 Nov 01; 73(11):466, 468, 470. PubMed ID: 6361177
    [No Abstract] [Full Text] [Related]

  • 15. Hydralazine in chronic CHF.
    Chatterjee K, Rouleau JL, Massie BM.
    Acta Med Scand Suppl; 1981 Nov 01; 652():99-113. PubMed ID: 6949469
    [Abstract] [Full Text] [Related]

  • 16. Vasodilators and ventricular septal defect: comparison of prazosin, minoxidil, and hydralazine in a chronic lamb model.
    Boucek MM, Chang R, Synhorst DP.
    Pediatr Res; 1984 Sep 01; 18(9):859-64. PubMed ID: 6483509
    [Abstract] [Full Text] [Related]

  • 17. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
    Laslett LJ, DeMaria AN, Amsterdam EA, Mason DT.
    Arch Intern Med; 1978 May 01; 138(5):819-20. PubMed ID: 646547
    [Abstract] [Full Text] [Related]

  • 18. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN.
    Circulation; 1993 Jun 01; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [Abstract] [Full Text] [Related]

  • 19. Long-term therapy with prazosin in severe chronic congestive heart failure.
    Bertel O.
    Cardiology; 1980 Jun 01; 65 Suppl 1():70-3. PubMed ID: 7379073
    [No Abstract] [Full Text] [Related]

  • 20. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L, Branea I, Riviş I, Radivoievici A, Mancaş S, Păunescu A.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983 Jun 01; 35(2):129-34. PubMed ID: 6139858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.